Thus, direct proliferative action of OPG on primary human breast cancer cells through reduction in TRAIL-induced apoptosis is a potential mechanism underlying breast tumorigenesis in vitro, though this requires confirmation in further in vivo studies. The gene discussed is TNFRSF11B; the disease is breast carcinoma.